Glimepiride Denk (Glimepiride)

Glimepiride Denk is prescribed for the management of type 2 diabetes mellitus when diet, exercise, and other oral agents are insufficient. It may be used as monotherapy or in combination with other antidiabetic agents.

• Improves glycemic control in adults with type 2 diabetes.
• Can be combined with metformin or thiazolidinediones when additional glucose lowering is needed.
• May be used when patients have not achieved target HbA1c with lifestyle measures alone.
• Suitable for patients who can tolerate sulfonylureas.
• Often considered after first‑line therapy with metformin has failed.

Glimepiride Denk may cause a range of side effects, most of which are mild and transient. Serious adverse events are less common but require medical attention.

Common

• Low blood sugar (hypoglycemia)
• Nausea or upset stomach
• Headache
• Dizziness or light‑headedness
• Weight gain
• Skin rash or itching

Serious

• Severe hypoglycemia leading to loss of consciousness
• Allergic reactions such as swelling of face or throat
• Liver enzyme elevations
• Blood disorders like leukopenia or thrombocytopenia

Before starting Glimepiride Denk, certain health considerations should be reviewed to minimize risks.

• Assess kidney and liver function, as impairment may affect drug clearance.
• Use cautiously in elderly patients who are more prone to hypoglycemia.
• Monitor blood glucose regularly, especially when initiating therapy or adjusting dose.
• Avoid use during pregnancy unless clearly needed; safety data are limited.
• Discontinue if signs of severe hypoglycemia occur.
• Inform healthcare providers of any history of cardiovascular disease.

Glimepiride Denk can interact with several medications, altering its effectiveness or increasing the risk of adverse effects.

Avoid

• Other sulfonylureas or insulin, which may cause additive hypoglycemia.
• Strong CYP2C9 inhibitors (e.g., fluconazole, amiodarone) that increase glimepiride levels.
• Certain antibiotics like co‑trimoxazole that potentiate hypoglycemia.

Use with caution

• Beta‑blockers, which may mask hypoglycemia symptoms.
• Thiazide diuretics, which can affect blood glucose control.
• Antifungal agents (e.g., ketoconazole) that may increase drug exposure.
• NSAIDs, which may impair renal function and influence drug clearance.